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Am J Med Genet Part A 9999A:1–13.The musculocontractural type of Ehlers-Danlos syndrome (MC-
EDS) has been recently recognized as a clinical entity. MC-EDS
represents a differential diagnosis within the congenital neuro-
muscular and connective tissue disorders spectrum. Thirty-one
and three patients have been reportedwithMC-EDS so farwith bi-
allelic mutations identified in CHST14 and DSE, respectively,
encoding two enzymes necessary for dermatan sulfate (DS) bio-
synthesis.We report seven additional patients withMC-EDS from
four unrelated families, including the follow-up of a sib-pair
originally reported with the kyphoscoliotic type of EDS in 1975.
Brachycephaly, a characteristic facial appearance, an asthenic
build, hyperextensible and bruisable skin, tapering fingers, insta-
bilityof large joints, andrecurrent formationof largesubcutaneous
hematomas are always present. Three of seven patients hadmildly
elevated serum creatine kinase. The oldest patientwas blind due to
retinal detachment at 45 years and died at 59 years from intracra-
nial bleeding; her affected brother died at 28 years from fulminant
endocarditis. All patients in this series harbored homozygous,
predicted loss-of-function CHST14 mutations. Indeed, DS was
not detectable in fibroblasts from two unrelated patients with
homozygous mutations. Patient fibroblasts produced higher
amounts of chondroitin sulfate, showed intracellular retention
of collagen types IandIII, andlackeddecorinand thrombospondin
fibrils comparedwith control.Agreatproportionof collagenfibrils
were not integrated into fibers, and fiber bundles were dispersed
into the ground substance in one patient, all of which is likely to
contribute to the clinical phenotype. This report should increase
awareness for MC-EDS.  2015 Wiley Periodicals, Inc.2015 Wiley Periodicals, Inc. 1
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INTRODUCTION
The musculocontractural type of Ehlers-Danlos syndrome (MC-
EDS; OMIM 601776), which is also referred to as Adducted
Thumb-Clubfoot Syndrome (ATCS; OMIM 601776), represents
a recently described autosomal recessively inherited condition
[D€undar et al., 2009; Kosho et al., 2010; Malfait et al., 2010;Miyake
et al., 2010; Syx et al., 2015]. Neonates with MC-EDS present with
distal arthrogryposis and muscular hypotonia. MC-EDS thus
represents a differential diagnosis within the congenital neuromus-
cular and connective tissue disorders. Characteristic features with a
spectrum of clinical symptoms have been reported in 34 patients
with MC-EDS, and bi-allelic mutations have been identified in
CHST14 (carbohydrate [N-acetylgalactosamine 4–0] sulfotrans-
ferase 14, OMIM 608429) in all but three patients [D€undar et al.,
2009;Malfait et al., 2010;Miyake et al., 2010; Voermans et al., 2012;
Winters et al., 2012; Mendoza-Londono et al., 2012; Syx et al.,
2015], who displayed DSE (dermatan sulfate epimerase, OMIM
605942) mutations [Muller et al., 2013; Syx et al., 2015]. CHST14
and DSE encode two enzymes that are necessary for dermatan
sulfate (DS) biosynthesis. DS proteoglycans are components of
diverse connective tissues and their deficiency and/or replacement
by chondroitin sulfate (CS) in proteoglycans such as decorin results
in abnormal regulation of collagen fibril assembly [Shimizu et al.,
2011].Moreover, DS interacts with heparin cofactor II and inhibits
thrombin in vessel walls following disruption of the endothelium,
and thus modulates thrombus formation [He et al., 2008].
In this study, we report seven additional patients from four
families with MC-EDS, including the oldest patient with this
condition described so far, and identify bi-allelic CHST14 muta-
tions in all probands. MC-EDS emerges further as a recognizable
condition with both consistent and variable clinical features,
known disease causing genes (CHST14 and DSE), and thus avail-
able molecular testing.
MATERIALS AND METHODS
Subjects
We evaluated seven individuals from four different families pre-
senting with a history of arthrogryposis, muscular hypotonia,
hypermobility of finger, elbow, and knee joints, and sub-luxations
of large joints, skin hyperelasticity and fragility, craniofacial dys-
morphism, and large subcutaneous bleedings.Molecular Studies
Written informed consent formolecular studies was obtained from
all participants, and the study was conducted in accordance with
the principles of the declaration of Helsinki.
We carried out a genome-wide linkage scan in family one using
the HumanCytoSNP-12v2 BeadChip (Illumina, CA) according to
the manufacturer’s instructions. Raw single nucleotide polymor-phism (SNP) call datawere processedwith theGenotypingAnalysis
Module in GenomeStudio 1.6.3 (Illumina). Homozygosity map-
ping was performed with the Merlin program [Abecasis et al.,
2002]. Detection of large homozygous chromosomal regions in the
index patient from family 2 was performed using the same SNP
array.
Direct genomic sequencing of the coding exon of CHST14 was
performed. Briefly, genomic DNA was isolated and a polymerase
chain reaction (PCR) amplified the coding regions and splice sites.
The PCRproducts were sequenced in both directions using sense or
antisense primers and the Big Dye terminator kit (Applied Bio-
systems, Vienna, Austria). The same primers (available upon
request) were used for PCR and sequencing reactions. Linear
amplification products were then separated on an automated
capillary sequencer (ABI 3100 Genetic Analyzer, Applied Biosys-
tems). Electropherogram-derived sequences were compared to
reference for CHST14 (NCBI ref.seqs.: NM_130468.2 and
NG_017074.1) using Sequencher software 4.8. To confirm genetic
segregation, relatives were tested for mutations detected in
probands.Cell Cultures
Primary dermal fibroblast cultures from individuals withMC-EDS
from families 1 and 2were established from skin biopsies by routine
procedures. Control samples were obtained from normal skin of
age- and sex-matched patients undergoing dermatologic proce-
dures. Fibroblasts were routinely maintained in Dulbecco’s modi-
fied Eagle medium (DMEM; PAA, Somerset) supplemented with
10% fetal calf serum (PAA, Somerset) at 37˚C in 5% CO2.
Fibroblasts were expanded until full confluency was achieved,
and then harvested by trypsin treatment at the same passage
number.Indirect Immunofluorescence (IF) Microscopy
Polyclonal antibodies (Abs) against collagen types I, III, and V and
mouse monoclonal Abs (mAbs) against collagen type VI (clone
3C4), a2b1 (clone BHA.2) and a5b1 (clone JBS5) integrins were
obtained from Millipore Chemicon International (Billerica, MA).
Ab against the human fibronectin (FN) andmAbs against all of the
human isoforms of tenascins (TNs), including tenascin C (TNC,
clone BC-24) and the CS glycosaminoglycans (GAGs; clone CS-
56), ascorbic acid, and tetramethylrhodamine isothiocyanate
(TRITC)-conjugated rabbit anti-goat antibody were from Sig-
ma–Aldrich (Taufkirchen, Germany). The anti-decorin (DCN)
mAb (clone 115402), recognizing the core protein, was from
R&D Systems, Inc. (Minneapolis, MN) and the anti-heparan
sulfate (HS) GAGs mAb was from USBiological Life Sciences
(Swampscott, MA). The anti-thrombospondin (TSP) mAb was
from NeoMarkers, Lab Vision (Fremont, CA). The fluorescein
isothiocyanate (FITC)-conjugated goat anti-rabbit and TRITC-
conjugated goat anti-mouse secondary Abs were from Calbio-
chem-Novabiochem Int. (San Diego, CA).
Fibroblasts used for IFmicroscopy were grown for 48 hr on glass
coverslips, as described above. To analyze the organization of the
collagen types I, III, and V, FN, and TN, cells were fixed in cold
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reported [Zoppi et al., 2004]. To analyze the collagen type VI
organization, fibroblasts were cultured for 7 days in the presence of
0.25mM ascorbic acid, refed every 48 hr, fixed in methanol and
immunoreactedwith the anti-collagen type VImAb. Thea5b1 and
a2b1 integrin organization was analyzed on cells fixed in 3%
paraformaldehyde (PFA)/60mM sucrose and permeabilized in
0.5% Triton X-100, and reacting for 1 hr at room temperature
with 1mg/ml anti-a5b1 and anti-a2b1 integrin mAbs. To analyze
the DCN, HS and CS GAGs, and TSP organization, the cells
were fixed for 10min in 3% PFA, and reacted with 25mg/ml
anti-DCN, 5mg/ml anti-HS GAG and anti-CS GAG and 1mg/
ml anti-TSPmAbs, respectively. Cells were subsequently incubated
for 45min with 10mg/ml FITC- or TRITC-conjugated anti-rabbit,
anti-goat, or anti-mouse IgG and IgM. IF signals were acquired by a
charge-coupled device black and white TV camera (SensiCam-
PCO Computer Optics GmbH, Germany) mounted on a Zeiss
fluorescence-Axiovert microscope and digitalized by Image-Pro
Plus program (Media Cybernetics, Silver Spring, MD).CHST14 Immunoblot and Quantitative RT-PCR
for CHST14 and DCN
Quantitative RT-PCR was performed as described previously
[Wang et al., 2008]. Briefly, total RNA was isolated from cultured
fibroblasts with the Absolutely RNApurification kit (Agilent, Santa
Clara, CA). Genomic DNA was removed by DNaseI treatment
following the manufacturer’s protocol. RNA was reverse tran-
scribed using SuperScript III (Life Technologies, Grand Island,
NY) and real-time PCR was performed on a Chromo4 (Bio-Rad)
with iQ SYBRGreen (Bio-Rad,Hercules, CA). All samples were run
in triplicate and results were normalized to the level of GAPDH.
The primer sequences are as follows: CHST14: 50-TCCAAGGAAA
GGAAAACGGA AG-30 and 50-CAGCCACAGT CACAACCTCA
AAG-30; DCN: 50-CATCTCTGCT GTTGACAATG GCTC-30 and
50-TGCTGAAAAG ACTCACACCC G-30; and GAPDH: 50-
ACTCCTCCAC CTTTGACGCT G-30 and 50-GGGTCTCTCT
CTTCCTCTTG TGCTC-30. cDNAs for CHST14, DCN, and
GAPDH were used as a template for PCR to obtain standard
curves. Immunoblot analysis for CHST14 was performed as de-
scribed previously [Wang et al., 2008] with anti-CHST14 antibody
(#ARP48994_P050, Aviva Systems Biology, San Diego, CA) using
Immuno-enhancer reagent (Wako, Richmond, VA). Monoclonal
anti-actin antibody (Sigma, St. Louis, MO) was used for loading
control of the samples.Glycosaminoglycan Analyses
Cultured fibroblasts in 10 cm dishes were dehydrated and delipi-
dated by extraction with acetone, air-dried, and used for extraction
of GAGs essentially as reported previously [Li et al., 2008] with
somemodifications. Briefly, the dried acetone powder was digested
with Proteinase K (Ambion, Grand Island, NY) in 200ml of 10mM
Tris HCl (pH 8.0) at 50˚C for 48 hr. Following incubation, samples
were treated with 5% trichloroacetic acid, and the resultant pre-
cipitate was removed by centrifugation. The supernatant was
extracted with ether to remove trichloroacetic acid. After neutrali-zation with 1M sodium carbonate, the aqueous phase was adjusted
to contain 80% ethanol and 1% sodium acetate and kept at
4˚C overnight. The precipitated crude GAGs were recovered by
centrifugation. One half of the crude GAGs was digested with
chondroitinase B (Sigma, St. Louis, MO) in 10mMTris HCl buffer
(pH 7.5) for 16 hr. The other half was digested with chondroitinase
ABC (Seikagaku, Tokyo, Japan) in 20mM Tris acetate buffer (pH
8.0) for 16 hr. The digests treated with 80% ethanol were centri-
fuged and the supernatants containing the disaccharides were
recovered and ethanol was evaporated. Cleaved saccharides were
separated in 150mM ammonium bicarbonate with size-exclusion
chromatography (Superdex Peptide, 1.0 30 cm, GE Healthcare
Life Sciences, Piscataway,NJ) attached to a ShimadzuUFLC system
at a flow rate of 0.3ml/min. Unsaturated disaccharides were
monitored by absorbance at 232 nm. CS-B (DS from Sigma)
was used as a positive control for chondroitinase digestions and
size fractionations. Fractions containing disaccharides were col-
lected and repeatedly evaporated; the resulting disaccharides were
labeled with the fluorescent tag 2-AB (Sigma) and disaccharide
composition was analyzed with HPLC [Wang et al., 2008].
RESULTS
Clinical Findings
The main clinical findings of the four index patients and the three
affected sibs together with those MC-EDS patients published
previously are listed in Table I. There were common characteristic
craniofacial features (Fig. 1), as well as common features of the
hands and feet (Fig. 2). The parents of all patients were healthy.
The clinical history of the Pakistanian siblings P1/I and P2/I
(Figs. 1 and 2) from birth until 20 and 18 years of age, respectively,
has been reported [Steinmann et al., 1975; Steinmann et al., 2002].
Their parents were first-degree cousins, and the two younger
brothers were healthy. Female P1/I was born at term weighing
2,700 g. There were clubfeet, marked muscular weakness, weak
crying, inability to suck and bottle-feeding possible only by use of
teat with especially large opening. The skull was reported to be very
soft (like a “balloon filled with water” until age 8 months) and the
skinwaspaper-thin. She sat at oneyear andwalked at three andahalf
years of age. Her hips dislocated without significant trauma at age
19 years.
Intellectual development was normal, and she was a university
student at 20 years of age. She measured 153 cm, weighed 57 kg,
head circumference 53.5 cm, with narrow shoulders, heavy thighs
and legs and flat thorax, and arm span of 141 cm. She had small
mammae and inverted nipples. On clinical examination, her
muscle mass appeared greatly decreased.
Laxity of joints, frequent bruising, delayed wound healing, skin
fragility with prolonged bleeding, and dermal hyperelasticity were
present. Grasping her hand was like taking a cherry stone pillow.
There was hyperalgesia to pressure, so that even blood pressure
measurements were painful. Electromyogram (EMG) and creatine
kinase (CK) were normal. She had a moderate scoliosis, and
radiographs showed that the vertebral bodies were narrow, high
and osteophytic. Diaphyses of phalanges and metacarpals were
narrow with thickening of the corticalis and markedly reduced
marrow space, and the metaphyses were osteoporotic. She frac-
TABLE I. Features Associated With CHST14 Mutations (Including
Indels) and with Two DSE Mutations in MC-EDS Patients Reported
in This Study and in the Literature
Always present
Habitus/skeletal/muscular
Congenital multiple contractions
Generalized joint laxity
Scoliosis, kyphoscoliosis (increasing with age)
Myopathy, muscular weakness, decreased muscle mass
Tapering/slender and cylindrical fingers
Fine palmer creases
Craniofacial
Hypertelorism
Protruding, large, low-set, posteriorly-rotated or dysplastic ears
Short nose, long philtrum
Bleeding disorder
Large subcutaneous hematomas
Cryptorchidism in males
Mostly present (>90% of individuals)
Habitus/skeletal/muscular
Marfanoid or asthenic habitus
Pectus deformities
Recurrent/chronic joint dislocations
Gross motor delay
Craniofacial
Large fontanelle
Down-slanting palpebral fissures
Blue sclerae
Small mouth (early childhood)
Thin upper lip
High palate
Prominent nasolabial folds in childhood
Skin
Hyperextensible to redundant skin with bruisability, atrophic scarring
Hyperalgesia to pressure or tension (such as measuring blood pressure)
Common (>50% of individuals)
Craniofacial
Microretrognathia
Strabismus
Myopia, astigmatism
Elevated intraocular pressure, glaucoma
Retinal detachment (following glaucoma surgery and age-related)
Skin
Recurrent subcutaneous infections
Cardial
Heart valve abnormalities (possibly increasing with age)
Gastrointestinal
Constipation
Occasional anomalies
Cleft lip/cleft palate
Craniosynostosis
Hearing impairment
Cerebral ventricular enlargement
Pneumothorax
Congenital heart defects
Anomalous insertions of flexor muscles
Absence of gastrocolic omentum, common mesentery, volvolus of small
intestine, intestinal malrotation, diverticular perforation
Inguinal hernia
Horseshoe kidney
Nephrolithiasis, hydronephrosis
Bladder dysfunction
Data from 34 persons with MC-EDS from 22 unrelated families were included in this compilation;
no clinical details were available from 3 deceased subjects.
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her quadriceps tendon, and hyperelasticity of her cruciate liga-
ments was judged extraordinary on surgery. She acquired large
cutaneous and subcutaneous hematomas following minor trauma,
and had a prolonged bleeding time with normal clotting factors.
She had down-slanting palpebral fissures, bluish sclerae, micro-
corneae (diameter 9–10mm), myopia (-2 diopt.), a few circum-
script retinal degenerations at the periphery but no signs of retinal
detachment. She experienced retinal detachment on both eyes at
45 years of age, causing right-sided blindness. The patient died at
age 59 years after she fell to the ground and was found to have a
large intracerebral hemorrhage as the cause of death.
P2/I, the younger brother of P1/I, was born at term weighing
2,720 g. His development and clinical course such as muscular
hypotonia, feeding difficulties, gross motor delay, and growth
along the 3rd centile were similar to that of his older sister. His
Achilles tendons were lengthened at age 5 years, and abnormal
flaccidity and fragility of all soft tissues were noted. Frequent
bruising, vulnerability of skin and prolonged bleeding were
reported throughout childhood. Large subcutaneous haematomas
of legs frequently required surgical removal. At 18 years of age, he
measured 175 cm and weighed 46.5 kg, with a head circumference
of 55 cm, an arm span of 170 cm, and a slender build (as opposed to
his sister) with slim arms and legs, and arachnodactyly (positive
wrist sign, negative thumb sign). He had down-slanting eyes,
drooping lower eyelids, bluish sclerae, myopia (-2 diopt.), micro-
corneae (8–9mm) but no signs of retinal detachment, and poste-
riorly-rotated very soft and floppy ears. He had mild scoliosis. He
had one small and one undescended testicle. On clinical examina-
tion, his muscle mass appeared greatly decreased. He had mitral
valve prolapse with moderate insufficiency and hyperalgesia to
pressure such as measuring blood pressure. The bleeding time was
repeatedly prolonged with normal coagulation factors. Serum CK
at age three and half years was normal.
He died at 28 years of age from fulminant endocarditis despite
the prescribed endocarditis prophylaxis.
P3/II (Figs. 1 and 2), a Hispanic boy, was born at term to first
cousins once removed, with birth weight 2.9 kg, and length
45.7 cm. Three older sibs were healthy. Prenatal ultrasound at
17 weeks of gestation suggested hand and foot anomalies.
Skeletal survey at birth showed possible intracranial calcifica-
tions that could represent resolving hematomas, and the skull was
very thin over the fronto-parietal region. He was referred to
Medical Genetics at 2 weeks of age for multiple congenital anoma-
lies, i.e., hypotonia, bilateral adducted thumbs, bilateral clubfeet,
bilateral inguinal hernias, and bilateral undescended testes. Serial
casting of feet from 3 to 12 weeks of age was followed by a Dennis
Browne splint for 3 months, and Achilles tendon release.
He underwent surgeries for bilateral inguinal hernias and unde-
scended testes, as well as surgery for bilateral extensor tendon
transfers from the ulnar dorsal side of the hand to the thumb
extensor at 1 year of age. During surgery he was found to have a
singleflexor tendon to the thumbsanda single tendon to thedorsum
of the indexfingers. Significant joint laxity andweaknesswerenoted.
At 19 months of age, paper-thin, pale distensible skin with
multiple bruises, and muscular hypotonia were noted. He was
unable to support himself in a sitting or standing position. He had
FIG. 1. Characteristic craniofacial aspects of MC-EDS. Note hypertelorism, down-slanting palpebral fissures, microcorneae, prominent
nasolabial folds, a thin upper lip vermillion, prominent and often low-set and posteriorly-rotated ears. The face appears myopathic. These
aspects are present at different age. y, years; m, months.
FIG. 2. Characteristic findings of hands and feet of MC-EDS patients, and an example of hematoma-formation. Note arachnodactyly, partial
syndactyly, fine palmar creases, and tapering fingers and toes. Radiographs show congenital talipes valgus and planus, with slight diaphysial
narrowing of the phalanges and metatarsals in infancy, and marked narrowing of diaphyses of metatarsals and phalanges, and osteoporotic
metaphyses in P2/I at age 18 years. (some figures of P1/I and P2/I are taken from [Steinmann et al., 1975] with permission of the Publisher
and from [Steinmann et al., 2002], respectively).
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and adducted thumbs. Language skills and social development
were normal. CK was 3,000U/L (<305) and Ullrich congenital
muscular dystrophy was suspected.
At age 2 years, he developed epidural bleeding associated with
obstructive hydrocephalus after a minor fall and required surgical
evacuation. He still had a widely patent anterior fontanelle. Every
2–4 months after 2 years of age, he had extensive soft tissue and
joint hemorrhages followingminor trauma, primarily affecting the
knees, buttocks, and thighs. The frequency of soft tissue bleeds
decreased markedly after age 5 years.
When seen at age 6 years, he had soft, doughy elastic skin, thin
scarring, and lax joints. Dysmorphic features included flat facies
with malar hypoplasia, hypertelorism with down-slanting palpe-
bral fissures, depressed nasal bridge, high arched palate, low set,
slightly posteriorly-rotated ears, short neck, and a shield chest with
widely spaced nipples. Microcornea was apparent but the cornea
diameter was not measured. Remarkably, he was hypersensitive to
tactile stimuli such as applying or removing an electrocardiogram
(ECG) electrode. His cognitive development was normal. At age
8 years, he was able to communicate by email. He does not
participate in normal sport activities for fear of injury. Fresh frozen
plasma and desmopressin (DDAVP, 1-Desamino-8-D-Arginine-
Vasopressin) administration were considered beneficial in the case
of hemorrhage.
Cranial magnetic resonance imaging (MRI) scans revealed
normal findings at 5 weeks, and at 26 months of age. Magnetic
resonance angiography did not detect any vascular malformations.
He had a prolonged bleeding time and a decreased ristocetin
response on platelet aggregometry. There were normal results
for complete blood counts (CBC), platelets, prothombin time
(PT), partial prothrombin time (PTT), fibrinogen, factors 8, 9,
11, and 13, platelet function testing (PFA-100), alpha-2 antiplas-
min, von Willebrand disease, plasminogen activator inhibitor-1,
tissue plasminogen activator, collagen-specific platelet glycopro-
teinIb/IIb/IIIa surface receptors, overall fibrinolysis asmeasured by
the euglobulin lysis time and shear wave elastography quantifica-
tion of blood elasticity during clotting. SerumCK levels weremildly
elevated at serial measurements (1.5 years: CK 2,944U/L; normal
range 60–305), 2 years: 878U/L (<228), 3.5 years: 336U/L (<149),
5.5 years: 405U/L (<149)). An echocardiogram at 5 years of age
was normal.
P4/III (Figs. 1 and 2), the index patient, was a girl born by
emergency Cesarean section at 42 weeks gestation to healthy
Hispanic parents, who denied consanguinity. The infant emerged
with poor respiratory effort and Apgar scores of 1 at 1 min and 8 at
5min. The birth weight was 3,180 g, length was 45.5 cm, and head
circumference (OFC) was 33 cm. The child had multiple craniofa-
cial anomalies with brachycephaly, hypertelorism, down-slanting
palpebral fissures, a broad nasal bridge and a shallow palate. Her
skeletal findings comprised bilateral talipes equinovarus, which
were reducible and bilateral adducted thumbs which were difficult
to extend. She had muscular hypotonia. She required oxygen over
the first 24 hr and had feeding difficulties secondary to a poor and
uncoordinated suck. However, she did not require tube feeding.
She had mild sensorineural hearing loss on the right with normal
hearing on the left. She had a normal cranial ultrasound, a normalcranial computerized tomography (CT) scan and MRI scan, a
normal echocardiogram and a normal skull radiograph. She was
discharged home at 5 days of life with mild jaundice and improved
feeding.
She was followed intermittently in Genetics clinic until age 7
when, despite gross motor delays, cognition was normal, head
circumference was 49 cm, and she was doing well in school. Serum
CK level was elevated at one measurement (CK 698U/L; normal
range 39–189U/L). She also had a history of recurrent joint
dislocations with at least three episodes of glenohumeral disloca-
tion resulting from minimal trauma. She developed a large tem-
poral hemorrhage after minor trauma. Based on clinical findings,
she was suspected to have MC-EDS.
P5/III (Figs. 1 and 2), the 6-year younger brother of P4/III, was
born by repeat Cesarean section at term due to oligohydramnios
and decreased fetal movement. Apgar scores at 1 and 5min were 8
and 9, respectively. The birth weight was 3,225 g. Multiple cranio-
facial anomalies included brachycephaly, hypertelorism, down-
slanting palpebral fissures, bilateral talipes equinovarus and
adducted thumbs. Neurologically, he had hypotonia and weak
suck, and like his sister, he stayed in hospital after birth due to
feeding difficulties. At 4 months of age, head circumference was
40 cm, a cranial ultrasound showed mild ventriculomegaly, a
cranial MRI was normal and a skeletal survey showed talipes as
described above. Serum CK level was elevated at one measurement
(CK 1838U/L; normal range 39–189U/L).
Both sibs had blue sclerae, apparent microcornea (cornea
diameter not measured), low-set and posteriorly-rotated ears,
downturned corners of the mouth, micrognathia, fine palmar
creases, reduced distal muscle bulk, soft and doughy skin and
long and tapering fingers. The girl had glaucoma from age 3 years
that required medical and surgical management. Her EMG was
myopathic, and a muscle biopsy showed lipid and glycogen accu-
mulation with mitochondrial hypertrophy.
P6/IV, the index, is a 4-year-old girl born at term by normal
spontaneous vaginal delivery to a 30-year-old mother and a
31-year-old father of Hispanic descent. Consanguinity was not
reported, but the parents came from the same village in Mexico.
Birth weight was 3,200 g and length was 47 cm. After birth, she was
noted to have distal arthrogryposis with bilateral clubfeet and
bilateral hand deformity. At age 1 month, she had casting for
talipes for 5 weeks and then wore braces at night for a period of
time.
At age 4-years her lengthwas 111 cm andweight was 23.2 kg.Her
distinctive craniofacial features included low-set posteriorly-rotat-
ed ears with prominent and overfolded helices, bilaterally attached
lobules, hypertelorism with down-slanting palpebral fissures, blu-
ish sclerae, and apparent microcornea (cornea diameter not mea-
sured). Dimples were present in the shoulders and elbows. She had
ulnar deviation of her handswith abnormal shallow palmar creases.
Fingers and toes had a spatula-like appearance. Her skin felt
doughy. Psychomotor development was normal. Following nega-
tive genetic work-up for Freeman-Sheldon syndrome, she was
suspected to have MC-EDS on clinical findings.
P7/IV, the younger brother of P6/IV, was born at term by
spontaneous vaginal delivery; a left foot contracture and right
hand contracture were diagnosed prenatally. Birth weight was
JANECKE ET AL. 72,860 g and length was 48 cm. Apgar scores were 9 at 1 and 5min.
After birth, contractures of extremities were confirmed, and he had
an undescended testis and dysmorphic features. He had casting of
his left clubfoot and left tendon Achilles tendon lengthening.
At age 18-months his length was 80 cm, weight was 10 kg and
head circumference 47.5 cm. Several dysmorphic craniofacial fea-
tures were noted: low-set posteriorly-rotated ears with prominent,
cupped helices and bilaterally attached ear lobules, hypertelorism
with down-slanting palpebral fissures, bluish sclerae, and apparent
microcorneae. He had ulnar deviation of the right hand with
abnormal, shallow palmar creases. His fingers and toes had a
spatula-like appearance. Severe eczema was noted. Psychomotor
development was normal. Echocardiography was recommended
but not performed on either sibling.Molecular Genetic Investigations
P1/I and P2/I were clinically diagnosed with EDS at 5 and 3 years of
age, respectively, in 1959, and with EDS VI due to an apparent
deficiency of collagen lysyl hydroxylase in cultured skin fibroblasts
producing hydroxylysine-deficient collagen by the Manchester
group. However, the hydroxylysine content was only moderately
reduced in dermis and was normal in tendon and bone as deter-
mined by the Zurich group [Steinmann et al., 1975], who alluded to
this biochemical discrepancy in the title of the paper. Later studies
could not confirm the deficiency of lysyl hydroxylase activity by
direct [Royce et al., 1989] or indirect measurement [Royce et al.,
1989; Steinmann et al., 2002] and the disease was called EDSVIB by
Victor McKusick as opposed to EDS VIA with enzyme deficiency.
Finally, homozygosity mapping in this family, including both
affected and two unaffected sibs, identified four candidate regions
on chromosomes 8, 9, 11, and 15. The chromosome 15 Locus
containedCHST14, which had been reported to bemutated inMC-
EDS/ATCS at the time of the linkage analysis [D€undar et al., 2009;
Miyake et al., 2010]. The shared clinical features with published
MC-EDS/ATCS patients prompted CHST14 sequence analysis. A
homozygous c.453dup (p.(Cys152Leufs10)) mutation causing
early protein truncation was found to segregate with the disease
in the family. Array-based high-resolution chromosome analyses
were normal in both patients. The parents were heterozygous for
the same mutation.
P3/II underwent sequencing of COL3A1, COL6A1, and
COL6A2, which ruled out initial diagnoses of the vascular type
of EDS (OMIM 130050) and Ullrich muscular dystrophy/Bethlem
myopathy (OMIM 254090 and OMIM 158810), respectively. A
SNP array analysis revealed a 26 Mb-region of homozygosity on
chromosome 15q15.1 in the patient but not in the two unaffected
sibs. This region contained CHST14, which was found to harbor a
homozygous c.638G>C (p.(Arg213Pro)) mutation. The same
mutation had been reported previously in a patient with ATCS
and affects an invariably conserved residue of CHST14 [D€undar
et al., 2009]. Array-based high-resolution chromosome analysis
was normal in the patient. The parents were heterozygous for the
same mutation.
P4/III, the index,was suspectedwithMC-EDSwhichwas proven
by the homozygous c.977_980dup (p.(Trp327Cysfs29)) mutation
of CHST14 in her as well as in her younger brother P5/III. Hermother was heterozygous for this change. Samples from the father
and her younger sibling were unavailable and thus a deletion on the
paternal allele rather than homozygosity for the same mutation
cannot be excluded. The identified frameshift mutation causes a
truncation of the 49 C-terminal residues of the wild-type protein.
Array-based high-resolution chromosome analyses were normal in
both children.
P6/IV was suspected to have MC-EDS, which was proven by the
homozygous c.784G>A(p.(Glu262Lys))mutationofCHST14 in P6/
IV and her affected brother P7/IV, while the parents were heterozy-
gous for thismutation.This novelmutation affects a highly conserved
residue in CHST14. Array-based high-resolution chromosome anal-
yses were normal in both children. Testing for Freeman-Sheldon
syndrome (OMIM 193700) had been performed prior to CHST14
testing including sequencing and deletion/duplication analysis of the
TNNI2, TNNT3, MYH3, and TPM2 genes and the results were
normal. The parents were heterozygous for the same mutation.
Altogether, CHST14 mutations were identified in all probands,
bringing the total number of known CHST14 mutations to 18, of
which 8 are protein-truncating mutations and 10 are missense
mutations (Fig. 3).Immunostaining of Fibroblasts and Electron
Microscopy
To investigate the pathophysiological consequences of CHST14
deficiency, the distributions of well-characterized ECM proteins
were examined in cultures of dermal fibroblasts derived from P1/I
and P2/I with the homozygous p.(Cys152Leufs10) mutation.
These cells were not covered by a reticular ECM of FN and TNs,
as compared with control skin fibroblasts. The highly decreased
levels of TNs assembled in the ECM of CHST14-deficient cells
suggest a significant reduction of TNC as well. Patient fibroblasts
lackedDCNandTSPfibrils in theextracellular environment, andFN
and fibrillar collagen receptors a5b1 and a2b1 integrins, respec-
tively, on the cell surface. The mutant cells showed intracellular
retention of collagen types I and III, and a reduced deposition of
collagen types I, III, V and VI fibrils in the ECM, as compared to
control fibroblasts. These cells produced and stored higher amounts
of CS GAG in the cytoplasm, which was not organized in the ECM,
and normal amounts of HS GAG as compared with control fibro-
blasts (Fig. 4). Previous investigation of the reticular layer of dermis
fromP2/I by electronmicroscopy revealed that a great proportionof
collagen fibrils was not integrated into fibers and fiber bundles. As a
result, fiber bundles were poorly delineated, and non-integrated
fibrils formed a rather irregular texture (Fig. 5).Analysis of Glycosaminoglycan Chain
Composition, CHST14 and DCN Expression
A fifty percent reduction in CHST14 mRNA was found in P3/II
fibroblasts with the homozygous p.(Arg213Pro) mutation
(Fig. 6A). This reduction was confirmed on the protein level by
immunoblot analysis (Fig. 6B), whereas DCN mRNA, encoding
one of themajorDSproteoglycans [Moreth et al., 2012], showedno
substantial changes compared to control fibroblasts.
FIG. 3. Schematic compilation of known CHST14 mutations. In gray, novel mutations; underlined, recurrent mutations found in unrelated MC-
EDS patients; above missense mutations, below truncating mutations.
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(Cys152Leufs10) and p.(Arg213Pro) mutations on carbohydrate
properties, GAG fractions were prepared from cultured fibroblasts
of patients P1/I and P3/II and were extensively digested with either
chondroitinase ABC or chondroitinase B. Whereas chondroitinase
ABC generates disaccharides fromCS as well as DS, chondroitinase B
converts only DS to disaccharides. Very small amounts of DS were
detected infibroblasts frompatientP1/IandP3/IIbychondroitinaseB
digest,whereas similar totalamountsofdisaccharides fromCSandDS
digests bychondroitinaseABCweregenerated incontrol andpatients0
fibroblasts, indicating that CS production in patient fibroblasts was
increased (Fig. 7). To further define the alteration in their GAGs,
disaccharide fractions were collected and composition analyses were
performed (Table II). While the major sulfation of chondroitin/
dermatan sulfate was 4-sulfation (35.5%) in control fibroblasts and
in fibroblasts with the homozygous p.(Cys152Leufs10) mutation,
the homozygous p.(Arg213Pro) mutation in CHST14 reduced 4-
sulfation (10.7%), possibly via binding of the residualmutant enzyme
to GAGs without any 4-sulfation activity but thereby blocking access
of other chondroitin sulfotransferases. Both mutations resulted in
increased 6-sulfation (52.6 and 58.7%).DISCUSSION
Musculocontractural EDS (MC-EDS) represents one of several
recently recognized disorders of GAG synthesis [Mizumoto et al.,
2013]. Because of variability in severity of clinical presentation, the
disorder has received the different designations of ATCS, EDS
Kosho type, EDS type VIB and D€undar syndrome [D€undar et al.,
2009; Kosho et al., 2010; Malfait et al., 2010; Miyake et al., 2010;
Shimizu et al., 2011 Kosho et al., 2011; Janecke et al., 2011;
Mendoza-Londono et al., 2012]. Recently, it has been classified
among the Ehlers-Danlos syndromes because of shared common
characteristics, such as joint hypermobility, skin hyperextensibility,
and tissue fragility [De Paepe and Malfait, 2012]. MC-EDS types 1
and 2 are distinguished by the underlying mutations in CHST14
(OMIM 601776) and DSE (OMIM 615539), respectively.Our identification of seven additional patients with MC-EDS
increases awareness of the condition and corroborates our knowl-
edge regarding the clinicalmanifestations. Furthermore, this report
should facilitate patient identification for targeted molecular anal-
ysis of MC-EDS. Indeed, the diagnosis of MC-EDS was made on
clinical findings in the index patients of families III and IV at 7 and
4 years of age, respectively, just after the molecular basis of MC-
EDS was established, and targeted mutation analysis was initiated.
The patients of families I and II (P1/I, P2/I, and P3/II) were
diagnosed with MC-EDS based on results from homozygosity
mapping and subsequent CHST14 analysis.
Our current study and previous reports on MC-EDS point out
that MC-EDS can be recognized based on the presence of congeni-
tal distal arthrogryposis, i.e., adducted thumbs or clenched fists and
talipes equinovarus, as well as hands with atypically shallow palmar
creases, tapering fingers, neonatal muscular hypotonia, and char-
acteristic craniofacial features (Table I). The latter consist of
brachycephaly, large fontanelle, hypertelorism, down-slanting pal-
pebral fissures, microcorneae, strabismus, a short philtrum, prom-
inent nasolabial folds, a thin upper lip vermillion, small mouth and
high palate, microretrognathia, prominent and often low-set and
posteriorly-rotated ears. MC-EDS patients show muscular hypo-
plasia and weakness, which has been confirmed by ultrasound and
electromyography [Voermans et al., 2012]. Mildly elevated CK
levels have so far been reported in one case of MC-EDS, and CK
levels have been normal in all other reported patients; our finding
of mildly elevated CK levels in three of seven patients supports the
evidence for a myopathy in MC-EDS. Distal arthrogryposis and
myopathy might explain the delayed motor development in all
reportedMC-EDS patients. Our series of patients confirms current
knowledge that intellectual development in this disorder is normal.
The pattern of clinical findings at birth should allow to distinguish
between MC-EDS and other differential diagnoses of hypotonic and
weak infantwitharthrogryposis, i.e., congenitalmusculardystrophies
such as laminin a2 deficiency (OMIM 607855), congenital myopa-
thies, congenital myasthenic syndromes, congenital metabolic my-
opathies, very early spinal muscular atrophy (SMA, OMIM 253300),
FIG. 4. Representative micrographs depicting immunodetection of ECM components in 2-day-old cultures of dermal fibroblasts derived from
skin biopsies from P1/I and P2/I. Mutant fibroblasts show increased intracellular levels of CS GAGs, that are not organized in the ECM, lack of
DCN and TSP fibrils, and reduced deposition of collagens I, III, V and VI, FN and TNs. The FN and fibrillar collagens receptors a5b1 and a2b1
integrins, respectively, are not recruited on the mutant cells membrane. Scale bar: 10mm.
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FIG 5. EM of the reticular layer of dermis from P2/I (lower
panel) shows that a great proportion of collagen fibrils is not
integrated into fibers and fiber bundles but dispersed into the
ground substance as compared with a control (upper panel).
Consequently, fiber bundles are poorly delineated, and non-
integrated fibrils form a rather irregular texture; (taken from
[Steinmann et al., 1975] with permission of the Publisher) Scale
bar: 50 mm.
FIG. 6. CHST14 p.(Arg213Pro) mutation causes a reduction of
CHST14 mRNA and CHST14, but not DCN mRNA. (A) RNA was
prepared from cultured fibroblasts and quantitative RT-PCR was
performed. Open bar, control fibroblasts; closed bar, P3/II
fibroblasts. Data are normalized to GAPDH. (B) Cell lysates were
prepared from cultured fibroblasts and subjected to immunoblot
analysis with anti-Chst14 antibody. Anti-actin antibody was
used for sample loading control.
10 AMERICAN JOURNAL OF MEDICAL GENETICS PART Athe kyphoscoliotic (OMIM 225400) and FKBP14-related (OMIM
614557) types of EDS, and Prader–Willi syndrome (OMIM 176270).
The collagen VI-related Ullrich muscular dystrophy and Bethlem
myopathy might emerge as differential diagnoses because hypermo-
bility of large joints can be seen with contractures of the small joints
simultaneously [Bonnemann, 2011]. The kyphoscoliotic type of EDS
(EDS VIA) shares some facial and dermal features with MC-EDS
[Rohrbach et al., 2011; Yeowell and Steinmann, 2013; Abdalla et al.,
2014];patientsP1/IandP2/IwereoriginallydiagnosedwithEDSVIA,
whichwas laterquestionedby theauthors.Theoriginal reportof these
two patients represents the first description of MC-EDS [Steinmann
et al., 1975].
MC-EDS patients develop a Marfanoid habitus with narrow
shoulders and spinal and pectus deformities. Hyperextensibility
and bruisability of the skin, a tendency to atrophic scars, hyper-
algesia to pressure, and recurrent subcutaneous hemorrhages arecommon. Endocarditis should be considered in MC-EDS patients
with sudden deterioration, as P2/I in this study died from fulmi-
nant endocarditis despite endocarditis prophylaxis, and endocar-
ditis in the presence of aortic and mitral valve regurgitation had
been treated by surgery in a 9-year-old MC-EDS patient [Kosho
et al., 2010]. Aortic and mitral valve regurgitation, mitral and
tricuspid prolapse, and aortic root dilation have occurred in several
MC-EDS patients, and warrant attention.
Formation of large subcutaneous hematomas with only minor
trauma represents a common and painful experience in MC-EDS,
increases the risk of hypovolaemia, and frequently requires surgical
treatment. Intranasal administration of 1-desamino-8-D-arginine
vasopressin (DDAVP) after injuries has been reported to prevent
furtherhematoma formation [Kosho et al., 2005;Kosho et al., 2010],
as in our patient 3/II. A prolonged bleeding time or a decreased
ristocetin response on platelet aggregometry with normal results for
standard blood coagulationparameterswas noticed in patients P1/I,
P2/I, andP3/II andwas reported in twopatients previously [D€undar
et al., 2009; Kosho et al., 2010]. However, three other patients had a
normal bleeding time [Kosho et al., 2005; Shimizu et al., 2011],
indicating that serial testing might be necessary to confirm blood
coagulation status. The hematomas have been hypothesized to be
caused by rupture of subcutaneous arteries or veins; the risk of
ruptureof arteriesor veinsof the brain and internal organs, as seen in
the vascular type of EDS [De Paepe and Malfait, 2012] and in the
FKBP14-EDS [Baumann et al., 2012], is difficult to estimate. The
potential for intracranialbleeding is suggestedby thesuddendeathat
59 years of age of P1/I in this series.
Our data also point to childhood or juvenile onset glaucoma,
retinal detachment and microcorneae as common findings in
MC-EDS. Cryptorchidism was present in all male patients to
FIG. 7. CHST14 mutations p.(Cys152Leufs10) and p.(Arg213-
Pro) identified in patients P1/I and P3/II, respectively, cause a
considerable reduction of DS, but not CS in fibroblast culture.
GAGs extracted from cultured fibroblasts of patients P1/I and
P3/II were digested with chondroitinase ABC (upper panel) and
chondroitinase B (lower panel), followed by size exclusion
chromatography. Disaccharides generated by chondroitinase
digestion were eluted at 40.8min as a peak (arrowhead).
Dashed line, control fibroblasts; solid line, P1/I fibroblasts;
dashed-dotted line, P3/II fibroblasts; dotted line, chondroitinase
digest of porcine intestinal DS used as standard reference.
TABLE II. Composition Analysis of Chondroitin/D
Chondroitinase ABC
% Mol Control P1/I
DDi-0Sa 16.88 4.16 1
DDi-4S 35.51 37.86 1
DDi-6S 28.89 52.58 5
DDi-2,6S 7.88 5.39
DDi-4,6S 10.84 0.00
DDi-2,4,6S 0.00 0.00
Extracted GAGs were digested with chondroitinase ABC and chondroitinase B, respectively. Disacch
aDDi-0S¼DHexUA-GalNAc; DDi-6S¼DHexUAGalNAc(6-O-sulfate); DDi-4S¼DHexUA-GalNAc(4-O-s
disulfate); DDi-2,4,6S¼DHexUA(2-O-sulfate)-GalNAc(4,6-O-sulfate); N.d., not detectable.
JANECKE ET AL. 11date probably due tomuscular hypotonia, and smallmammaewere
reported in post-pubertal female patients.
Counseling of families with MC-EDS regarding long-term
outcome and management, and reproductive plans is presently
based on the description of 34 affected persons from 22 unrelated
families [Steinmann et al., 1975; D€undar et al., 1997; Sonoda and
Kouno, 2000; D€undar et al., 2001; Janecke et al., 2001; Kosho et al.,
2005; D€undar et al., 2009; Kosho et al., 2010; Malfait et al., 2010;
Shimizu et al., 2011; Mendoza-Londono et al., 2012; Voermans
et al., 2012;Winters et al., 2012].MC-EDS had been established as a
disease entity by the identification of CHST14mutations at least in
the index patient of each family reported to date (Fig. 3), and by a
homozygous DSE mutation in three patients [Muller et al., 2013;
Syx et al., 2015].
CHST14 is a one-exon gene, and the mutant transcripts with
premature termination codons are predicted to be translated into
truncated proteins that completely or partially lack the sulfotrans-
ferase domain. The twomost C-terminal mutations result in loss of
the 42 and 49 C-terminal residues of the 376-residue protein. Eight
missensemutations are clusteredwithin or immediately adjacent to
the sulfotransferase domain, and seven of these mutations affect
highly or invariably conserved residues. Abnormal intracellular
enzyme processing and degradation, a decrease in sulfotransferase
activity, and/or deficiency of DS-derived disaccharides in fibro-
blasts have been demonstrated for sixmissensemutations [D€undar
et al., 2009; Miyake et al., 2010]. In this study, we confirmed by
disaccharide analysis of intracellular GAGs following chondroiti-
nase digests that fibroblasts derived from P3/II with a homozygous
p.(Arg213Pro) mutation do not produce DS because of decreased
CHST14 mRNA and CHST14 protein expression. Immunofluo-
rescent analysis on fibroblasts derived from P1/I and P2/I with a
homozygous CHST14 p.(Cys152Leufs10) mutation revealed in-
creased intracellular amounts of CS and an atypical retention of
collagen I (Fig. 5), findings consistent with the previous analysis of
fibroblasts with a homozygous p.(Arg274Pro) mutation [Men-
doza-Londono et al., 2012].
Biosynthesis of CS/DS is a process requiring at least 22 enzymes
directly involved in the assembly and modification of the chain;
CHST14 andDSE catalyze the conversion of CS toDS, the last steps
of this process, and introduce iduronic acid-containing domains inermatan Disaccharides in Fibroblasts of P3/II
Chondroitinase B
P3/II Control P1/I P3/II
7.25 40.97 N.d. N.d.
0.66 37.50 N.d. N.d.
8.67 8.18 N.d. N.d.
9.00 7.94 N.d. N.d.
4.41 5.41 N.d. N.d.
0.00 0.00 N.d. N.d.
aride fractions were labeled with 2-AB and composition analysis was performed.
ulfate); DDi-2,6S¼DHexUA(2-O-sulfate)-GalNAc(6-O-sulfate); DDi-4,6S¼DHexUA-GalNAc(4,6-O-
12 AMERICAN JOURNAL OF MEDICAL GENETICS PART Athe GAG chain. CHST14 and DSE deficiencies cause a shortage of
sulfated dermatan, while all prior enzyme deficiencies would affect
CS and/or heparin sulfate synthesis [Mizumoto et al., 2013]. DS
domains have a key role in mediating the functions of DS proteo-
glycans [Malmstr€om et al., 2012], and CS/DS proteoglycans are
found in the extracellularmatrix of the connective tissues including
basement membranes, at the cell surface, and intracellularly. DS
proteoglycans are found in blood vessel walls, skin, tendon, sclera,
cartilage, and undifferentiated mesenchymal tissues [Rosenberg
et al., 1985]. CHST14 mutations identified in MC-EDS patients
were shown or predicted to be loss-of-function mutations and
deficiency of CHST14 leads to a loss of DS and/or a partial
replacement of DS by CS and thus the CS type GAGs on proteo-
glycans such as decorin results in abnormal regulation of collagen
fibril assembly (Fig. 5) [Miyake et al., 2010]. Indeed, abnormal
collagen fibril andfiber distribution had originally been observed in
patient P2/I [Steinmann et al., 1975]. The sulfated polysaccharide
DS forms proteoglycans with a number of other core proteins, such
as biglycan and versican [Malmstr€om et al., 2012] whose deficien-
cies might also contribute to the range of clinical problems in MC-
EDS patients. Secreted biglycan interacts via its core protein or
GAG chains with type I, II, III, and VI collagen and elastin [Nastase
et al., 2012], and thus their tissue expression corresponds to the
phenotypic expression in MC-EDS.ACKNOWLEDGMENTS
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